Shared Content Block:
Styles -- modify testimonial colors
The mission of the RNA Bioscience Initiative (RBI) is to cultivate a vibrant center of discovery and innovation in RNA biology, informatics, diagnostics, and therapy. Our goal is to provide a fluid pipeline from basic to clinical RNA research at the Anschutz Medical Campus.
September 2, 2021
A phase I clinical trail to assess the ability of two mRNA vaccines to generate broadly neutralizing antibodies against HIV is set to begin recruiting participants in mid-late September.
August 23, 2021
The Pfizer-BioNTech mRNA vaccine against covid-19 has received full approval from the FDA, passing strict requirements for safety, effectiveness, and manufacturing quality.The FDA is expected to fully approve the Moderna mRNA vaccine later this fall.
September 1, 2021
The latest round of RBI Pilot Grants netted 59 applications and 20 awards. These awards will enable investigators from two different schools (School of Medicine and School of Pharmaceutical Sciences), representing seven unique departments and 6 divisions, to add RNA-based technologies to their research programs. Congratulations to all!
August 30, 2021
Congratulations to Lorraine Davis, Arely Diaz, Hei-Yong Grant Lo, and Cormac Lucas the RBI 2021-2022 RNA Scholars. These four graduate students were selected from a pool of 7 accomplished applicants. Each displays outstanding
promise toward advancing RNA biology.
RBI's Evan Morrison and his mentor, Olivia Rissland, have been selected as one of 50 new HHMI Gilliam student-advisor pairs. Gilliam fellowships are awarded to outstanding graduate students and their PhD mentors as part of a program to foster diversity and inclusion in biomedical or life science disciplines.
The NSF has awarded RBI's Dr. Olivia Rissand a prestigious Early Career Development award to study the maternal-to-zygotic transition in animal embryogenesis. The award will provide $1.3 million dollars of funding over five years.
RBI faculty members Matt Taliaferro, PhD and Chad Pearson, PhD, have been awarded a $1 million grant from the W.M. Keck Foundation for their project Control of cell division through centrosomal RNA localization. The goal of this study is to uncover the identity of centrosomal RNAs essential to the proper regulation of cell division. Given the links between centrosome dysfunction and cancer, it may reveal previously unidentified mechanisms that contribute to tumorigenesis.
The RBI has made CU Anschutz a clear hub of RNA biology expertise, raising the status of the university and its researchers in the eyes of scientists at institutions around the country and the world. The RBI sets CU Anschutz up as a leader in the exciting and groundbreaking field of RNA biology.
Amy Campbell, PhD